Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$1.58
-7.1%
$1.74
$1.21
$2.55
$11.86M76.75147,122 shs96,772 shs
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
$0.01
+11.1%
$0.01
$0.00
$0.03
$10.15M0.3682,451 shs677,736 shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.39
+11.2%
$1.21
$0.40
$1.68
$21.84M4.7919,323 shs2,178 shs
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$0.96
-1.0%
$0.80
$0.65
$0.99
$12.29M-0.0219,324 shs20,001 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-7.06%-5.95%+1.94%-10.23%-22.17%
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
+11.11%+2.04%-30.07%-35.06%-42.86%
Marpai, Inc. stock logo
MRAI
Marpai
+11.20%0.00%+6.92%+46.32%+69.51%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00%-1.03%+19.85%+31.51%+20.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
3.7165 of 5 stars
3.55.00.00.03.13.30.6
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
3.00
Buy$18.001,039.24% Upside
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$400K29.63N/AN/A$1.23 per share1.28
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
N/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.63N/AN/A($1.72) per share-0.81
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$6.07M2.02$0.07 per share13.38$0.91 per share1.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$8.98M-$1.47N/AN/AN/A-3,093.61%-129.47%-86.02%8/12/2025 (Estimated)
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
N/AN/A0.00N/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$1.82N/AN/A-85.70%N/A-100.23%8/5/2025 (Estimated)
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$880K$0.0713.72N/A15.18%8.47%7.97%8/5/2025 (Estimated)

Latest CUBT, MRAI, BRTX, and PFHO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 million
5/2/2025Q1 2025
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A$0.02N/A$0.02N/A$1.82 million
3/27/2025Q4 2024
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.27-$0.20+$0.07-$0.20$0.48 million$0.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/AN/AN/AN/AN/A
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
N/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/A
2.24
2.24
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
18.55
18.55
CompanyEmployeesShares OutstandingFree FloatOptionable
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
77.50 million5.59 millionNot Optionable
Curative Biotechnology, Inc. stock logo
CUBT
Curative Biotechnology
N/A1.02 billionN/ANot Optionable
Marpai, Inc. stock logo
MRAI
Marpai
15015.71 million5.61 millionNo Data
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
3012.80 million4.92 millionNot Optionable

Recent News About These Companies

PAHO warns of increase in yellow fever cases
PAHO warns of NCDs spreading in the region
Metro Pacific Health, mWell ink referral partnership
DLR Group Appoints Healthcare Design Project Leader for Pacific Northwest

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biorestorative Therapies stock logo

Biorestorative Therapies NASDAQ:BRTX

$1.58 -0.12 (-7.06%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$1.61 +0.03 (+1.90%)
As of 06/20/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.

Curative Biotechnology stock logo

Curative Biotechnology OTCMKTS:CUBT

$0.01 +0.00 (+11.11%)
As of 06/20/2025 03:46 PM Eastern

Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.39 +0.14 (+11.20%)
As of 06/20/2025 01:45 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Pacific Health Care Organization stock logo

Pacific Health Care Organization OTCMKTS:PFHO

$0.96 -0.01 (-1.03%)
As of 06/20/2025 12:30 PM Eastern

Pacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, employee advocate services, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves insurers, third party administrators, self-administered employers, municipalities, and other industries. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California.